Arkolith/Insider Trading/CVKD/Form 4

Szot Matthew K

Chief Financial OfficerCadrenal Therapeutics, Inc. (CVKD) · full profile →Form 4 · filed Oct 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$50K
Net Open-Market Flow
-$50K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 27, 2025Sell(S)2K$13.99$25K10K
Oct 24, 2025Sell(S)2K$13.99$25K12K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-25-103147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML